Cisplatin-, Doxorubicin-, and Docetaxel-Induced Cell Death Promoted by the Aqueous Extract of Solanum nigrum in Human Ovarian Carcinoma Cells
In conclusion, the AE-SN exhibited tumor suppression efficacy and improved the tumor suppression efficiency of cisplatin, doxorubicin, and docetaxel in human ovarian cancer cells. Therefore, the AE-SN is a candidate antitumor ingredient that can be used in developing future integrated chemotherapy for managing ovarian cancer.
Source: Integrative Cancer Therapies - Category: Cancer & Oncology Authors: Wang, C.-W., Chen, C.-L., Wang, C.-K., Chang, Y.-J., Jian, J.-Y., Lin, C.-S., Tai, C.-J., Tai, C.-J. Tags: Articles Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Chemotherapy | Docetaxel | Ovarian Cancer | Ovaries | Study | Taxotere